TP53 and cancer: Mut-p53 induces the UDPase ENTPD5, which favors the folding of N-glycosilated proteins, and alters the balance between the branches of the Unfoded Protein Respose (UPR), dampening the activity of IRE1α and PERK, while promoting ATF6 activation, ultimately resulting in increased cancer cell survival.